Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CogstateASX:CGS +0.73%75 EV-to-OCF is 30.78 as of Jul. 20, 2026, which is 21% above its 10-year median of 25.41. GuruFocus rates ASX:CGS with a GF Score™ of 75/100 and a GF Value™ of A$2.11 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Cogstate ranks worse than 87.87% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Cogstate's Enterprise Value is A$415.08 Mil.
Cogstate's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$13.49 Mil. Therefore, Cogstate's EV-to-OCF for today is 30.78.
The historical rank and industry rank for Cogstate's EV-to-OCF or its related term are showing as below:
ASX:CGS'
s EV-to-OCF Range Over the Past 10 Years
Min: -521.03 Med: 25.41 Max: 255.91
Current: 30.78
During the past 13 years, the highest EV-to-OCF of Cogstate was 255.91. The lowest was -521.03. And the median was 25.41.
ASX:CGS's EV-to-OCF is ranked worse than 87.87% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 8.83
vs ASX:CGS: 30.78
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cogstate's share price for today is A$2.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cogstate's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.094.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cogstate EV-to-OCF Related Terms
Cogstate EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Cogstate's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Cogstate's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cogstate EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Cogstate's EV-to-OCF falls into.
Cogstate's current Enterprise Value is A$415.08 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cogstate's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$13.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cogstate (ASX:CGS) has a EV-to-OCF of 30.78 as of Jul. 20, 2026. This is 21% above median its historical median of 25.41. According to the industry distribution chart, Cogstate ranks #601 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 87.9%.
Is Cogstate's EV-to-OCF too high?
Cogstate's current EV-to-OCF of 30.78 is 21% above median its 10-year median of 25.41. The Healthcare Providers & Services industry median EV-to-OCF is 8.83. Cogstate's value of 30.78 is 248.6% above this industry median. Based on the distribution chart, Cogstate ranks #601 out of 684 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cogstate has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's EV-to-OCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cogstate ranks #601 out of 684 companies for EV-to-OCF. This places Cogstate in the lower half of its industry. The industry median EV-to-OCF is 8.83. Cogstate's value of 30.78 is 248.6% above this benchmark. While the company's 10-year median is 25.41 vs. the industry median of 8.83, Cogstate has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.83, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cogstate's current EV-to-OCF of 30.78 is 248.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cogstate's current EV-to-OCF is 30.78, which is 21% above median its own 10-year median of 25.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (ASX:CGS) is currently considered Modestly Overvalued. The stock's GF Value™ is A$2.11, compared to a current price of A$2.75 — trading 30.3% above its estimated fair value. The current EV-to-OCF is 30.78, which is 21% above median its 10-year median of 25.41 and 248.6% above the Healthcare Providers & Services industry median of 8.83. Cogstate's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Cogstate (ASX:CGS), the current EV-to-OCF is 30.78 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cogstate (ASX:CGS) Overvalued in 2026?
Based on GuruFocus' analysis, Cogstate stock appears to be overvalued.
The current stock price of A$2.75 is trading 30.3% above its estimated GF Value™ of A$2.11.
GuruFocus considers Cogstate to be Modestly Overvalued.
Key valuation signals for ASX:CGS:
EV-to-OCF: 30.78 (21% above median its 10-year median of 25.41)
GF Value™: A$2.11 vs. price of A$2.75 (30.3% above fair value)
Industry Position: 248.6% above the Healthcare Providers & Services median (#601 of 684)
No single metric tells the full story. See the ASX:CGS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
75GF Score
Get the complete analysis for ASX:CGS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CGS has been successfully added to your 
